Development and Characterization of a Monoclonal Antibody Specific for Fucosyltransferase VII (Fuc-TVII): Discordant Expression of CLA and Fuc-TVII in Peripheral CD4+ and CD8+ T Cells  by Mizukawa, Yoshiko et al.
Development and Characterization of a Monoclonal Antibody
Speci®c for Fucosyltransferase VII (Fuc-TVII): Discordant
Expression of CLA and Fuc-TVII in Peripheral CD4+ and
CD8+ T Cells
Yoshiko Mizukawa, Kenya Shitara,* Yoshimi Yamazaki, Yuichi Teraki, Ryo Takahashi, Hisashi Narimatsu,²
and Tetsuo Shiohara
Department of Dermatology, Kyorin University School of Medicine, Mitaka, Tokyo; *Tokyo Research Laboratories, Kyowa Hakko Kogyo Co. Ltd.,
Machida, Tokyo; ²Division of Cell Biology, Institute of Life Science, Soka University, Hachioji, Tokyo, Japan
Although cutaneous lymphocyte-associated antigen
(CLA) is thought to be speci®cally expressed on skin
``homing'' T cells, it has become clear that CLA is
not directly involved in binding to E-selectin but
represents an excellent marker for high levels of
fucosyltransferase VII (Fuc-TVII): Fuc-TVII can
regulate the ability of T cells to migrate into the skin
by generating a binding site for E-selectin. In this
study, by using a novel monoclonal antibody for
Fuc-TVII, we investigated whether expression of
Fuc-TVII could be selectively detected in various
CLA+ cell lines and peripheral blood T cells. Fuc-
TVII was readily detected in the cytoplasm, but not
in the membrane, of CLA+ cell lines. Cytoplasmic
Fuc-TVII expression was also detectable in both
CD4+ and CD8+ T cells puri®ed from peripheral
blood mononuclear cells. Nevertheless, there were
signi®cant numbers of CLA-expressing CD4+ or
CD8+ T cells that did not coexpress Fuc-TVII, and
vice versa: either the CD4+ or the CD8+ T cell popu-
lation consisted of a variable ratio of CLA+ Fuc-
TVII+, CLA+ Fuc-TVII±, and CLA± Fuc-TVII+ cells;
and CLA+ Fuc-TVII± cells were the most abundantly
identi®able phenotype in peripheral blood CD4+ and
CD8+ T cells. Thus, according to their expression
pattern, skin ``homing'' T cells can be subdivided
into at least three populations, CLA+ Fuc-TVII+,
CLA+ Fuc-TVII±, and CLA± Fuc-TVII+ cells. Our
study provides convincing evidence that skin ``hom-
ing'' T cells are phenotypically heterogenous and
that Fuc-TVII expression, in combination with CLA
expression, is a useful phenotypic marker for identi-
fying skin ``homing'' T cells in mixed cell popula-
tions. Key words: cutaneous lymphocyte antigen/Fuc-
TVII/immunohistochemistry/T cell migration. J Invest
Dermatol 117:743±747, 2001
A
carbohydrate epitope recognized by a unique
monoclonal antibody (MoAb) HECA 452, called
cutaneous lymphocyte-associated antigen (CLA), is
thought to be of functional relevance for the
migration of distinct subsets of T cells into in¯amed
skin (Picker et al 1990a, b, 1991; Rossiter et al, 1994). Recent
studies have shown that the CLA epitope is an inducible
carbohydrate modi®cation of the protein core of P-selectin
glycoprotein ligand-1 (PSGL-1) (Fuhlbrigge et al, 1997). Because
the addition of fucose is the last step in the biosynthesis of sialyl-
Lewisx (sLex), expression of fucosyltransferases is a likely candidate
for an important regulatory step in selectin-ligand biosynthesis
(Maly et al, 1996). Several lines of evidence indicate that, among
®ve a (1, 3)-fucosyltransferases (Fuc-T) in hematopoietic cells,
Fuc-TVII is the most critical and irreplaceable enzyme that can
generate a binding site for E-selectin (Knibbs et al, 1996, 1998;
Nigel et al, 1996; Wagers et al, 1996; Fuhlbrigge et al, 1997).
Nevertheless, it has become apparent that the expression of HECA-
452-de®ned carbohydrates would be a good marker for high levels
of Fuc-TVII activity but not necessarily represent the epitope
required for recognition of E-selectin (Picker et al, 1991; Kansas,
1996; Wagers et al, 1996, 1997, 1998). This view is supported by a
number of recent studies: e.g., transfection of Fuc-TVII cDNA
alone was suf®cient to generate high avidity E-selectin ligands in all
cell types examined (Wagers et al, 1997). These ®ndings implicate
that CLA per se is only partially responsible for the selective
migration of T cells to the skin; and that Fuc-TVII determines the
level of E-selectin ligands on T cells, thereby regulating their
eventual migration into the skin (Knibbs et al, 1996, 1998; Wagers
et al, 1996, 1997, 1998). Thus, given that Fuc-TVII plays a crucial
role for the generation of E-selectin ligands, attention has focused
on identifying relevant expression of Fuc-TVII in T cells with skin
``homing'' properties; however, analyses of the expression of Fuc-
TVII in the T cell populations have been dif®cult, as the MoAb by
which expression of Fuc-TVII can be detected at the protein level
has not been available. Therefore, this study was undertaken to
establish a reliable immunohistochemical assay that would allow the
identi®cation of Fuc-TVII expression in cultured or freshly
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prepared T cells. This MoAb can identify a distinct subset of T cells
with skin ``homing'' properties that do not express CLA but would
be destined to become CLA positive.
MATERIALS AND METHODS
Cell lines and reagents The cell lines HL60, Jurket, and Namalwa
were maintained in RPMI 1640 supplemented with 10% fetal calf serum,
1% penicillin/streptomycin, and 2 mM glutamine. The Fuc-TVII-
transfeted Namalwa cell line was maintained in an analogous manner
except for the addition of G418 (Life Technologies, Gaithersburg, MD)
to maintain the transfected phenotype. HECA-452 MoAb was a kind
gift from L. Picker (University of Texas, South-western Medical Center,
Dallas, TX). MoAb against CD3 (Becton Dickinson, Mountain View,
CA), CD4 (Nichirei, Tokyo, Japan), CD8 (Dakopatts, Glostrup,
Denmark), CD33 (Becton Dickinson), and the respective isotype
controls were purchased commercially, respectively.
Preparation of recombinant human Fuc-TVII protein A plasmid
pQE-ST4 was constructed by inserting DNA fragment encoding C-
terminal portion of human Fuc-TVII (40±342) (Sasaki et al, 1994)
between Asp718 and BamHI sites of pQE-31 (Qiagen, Hilden,
Germany). Recombinant Fuc-TVII protein was expressed by E. coli
M15[pREP4] strain (Qiagen) harboring pQE-ST4 according to the
manufacture's recommendation. Recombinant Fuc-TVII protein
produced as an inclusion body was partially puri®ed as described
previously (Sekine et al, 1985) and was subjected to preparative SDS-
PAGE to obtain an antigen.
Hybridoma production and puri®cation of anti-Fuc-TVII MoAb,
KM1939 MoAb, KM1939 (mouse IgG1) was established by
immunizing BALB/C mice (Charles River Japan, Kanagawa, Japan) with
recombinant Fuc-TVII. The spleen cells were fused with mouse
myeloma P3U1 cells (Hanai et al, 1986a), and the culture supernatants of
the hybridomas were screened for their ability to recognize the
recombinant Fuc-TVII by enzyme linked immunosorbent assay (ELISA).
Positive hybridomas were cloned twice using the limiting dilution
technique. The established hybridomas were inoculated into the
peritonium of BALB/C nude mice (Charles River Japan). KM1939 was
puri®ed from ascites with caprylic acid (Sigma, St. Louis, MO) (Russo et
al, 1983).
Western-blot analysis Establishment of Namalwa cells stably
expressing each of four different human a (1,3)-Fuc-T genes, Fuc-TIII,
-TIV, -TVI, or -TVII were described previously (Sasaki et al, 1994).
Cell homogenates were prepared from these cell lines by the method
described previously (Hanai et al, 1986b). Thirty micrograms of protein
of each membrane was boiled for 5 min with SDS-PAGE sample buffer
(®nal concentration; 0.625 M Tris, 2% SDS, 10% glycerol and 0.001%
bromophenol blue) and was separated on SDS-PAGE gel (5±20%
gradient) and transfered onto PVGF membranes. The membranes were
blocked with 10% BSA in PBS and were incubated with 1 mg per ml
KM1939 diluted in PBS containing 10% BSA and 0.5% Triton X-100
for 2 h at room temperature. They were washed and were incubated
with peroxidase-labeled rabbit antimouse immunoglobulin (Dakopatts) at
room temperature for 1 h. For visualizing bands, the ECL Western
blotting detection system (Amersham Pharmacia Biotech, Uppsala,
Sweden) was used.
Preparation of puri®ed CD4+ and CD8+ T cells from peripheral
blood mononuclear cells After informed consent was obtained from
healthy volunteers, peripheral blood mononuclear cells (PBMC) from the
®ve blood donors were isolated by density gradient sedimentation over
Ficoll-Hypaque (Sigma, St. Louis, MO). Puri®ed CD4+ or CD8+ T cells
were isolated from the PBMC preparations by negative selection using
human CD4+ or CD8+ T cell subset column Kit (R&D Systems,
Minneapolis, MN) per manufacturer's recommendations. The isolated
CD4+ and CD8+ samples were highly enriched for CD4+ T cells and
CD8+ T cells, respectively: recovered CD4+ and CD8+ T cells showed
> 91.0% CD3+/CD4+ and > 92.3% CD3+/CD8+ purity, respectively,
as assessed by ¯ow cytometry. Of particular importance to our studies,
the isolated CD4+ or CD8+ T cell preparations contained in all instances
no or very few (< 1%) monocytes as evaluated by morphology and
CD33 expression.
Immunohistochemistry Immunohistochemistry was performed on
these cell lines and puri®ed CD4+ and CD8+ T cell preparations, as
previously described (Mizukawa et al, 2001). Brie¯y, the cells were
centrifuged onto microscope slides using a Sakura autosmear CF12D
(Sakura Seiki, Tokyo, Japan), air dried, and stored at ±80°C until used.
Visualization of Fuc-TVII activity was performed using streptavidin/
biotinylated horseradish peroxidase method. The slides were
counterstained with Mayer hematoxylin and mounted for light
microscopy. Negative controls were incubated with isotype-matched
mouse MoAb of irrelevant speci®city or PBS, instead of the primary
MoAb.
When double immunohistochemistry was used to detect the Fuc-TVII
enzyme in the cytoplasm and CLA in the cell membrane, cytoplasmic
staining for the Fuc-TVII as determined by the streptavidin-biotin-
staining procedure was performed ®rst and followed by membrane
staining for the CLA as determined by the avidin-biotin-alkaline
phosphatase complex (ABC-AP) and Vector blue detection system
(Vector Laboratories, Burlingame, CA).
Quanti®cation of stained cells Stained sections were assessed using
an Olympus BH-2 microscope in a blind fashion by two observers (YM
and YY) independently and there was no signi®cant difference between
assessment by the two. For each specimen at least ®ve randomly selected
®elds of areas were assessed under 4003 magni®cation. An average of
500 cells were counted per slide and the percentage of positively stained
cells was calculated. Double-stained cells were characterized if both red
and blue color could be discerned within one cell.
RESULTS
Establishment of MoAb against human Fuc-TVII We
established an antihuman Fuc-TVII MoAb, KM1939 (mouse IgG1)
from mice immunized with recombinant human Fuc-TVII as
immunogen: KM1939 selectively reacted with human recombinant
Fuc-TVII in ELISA (data not shown). Western blot analysis was
performed to de®ne the molecular weight of Fuc-TVII and
con®rm the speci®city of KM1939 (Fig 1). KM1939 speci®cally
recognized a 44-kDa Fuc-TVII protein existing in the Fuc-TVII-
transfected Namalwa cell line. No apparent bands were detected in
the Fuc-T III, -T IV, -T VI or mock transfectant Namalwa cells.
The additional 30 kDa band was also detected in the Fuc-TVII-
transfected Namalwa cell line. Because this band was exclusively
present in the Fuc-TVII-transfected cells, the 30 kDa band was
thought to be degradation products of the Fuc-TVII gene. These
Figure 1. Reactivity of KM1939 with Namalwa KJM-1 cells stably
expressing human a (1, 3)-Fuc T genes, Fuc TIII, -TIV, -TVI,
-TVII by western blot analysis. Experimental details are given in the
Materials and Methods. Membrane fractions of Fuc-TIII (lanes 1, 6), -TIV
(lanes 2, 7), -TVI (lanes 3, 8), -TVII (lanes 4, 9), or mock (lanes 5, 10)
transfectant cells were immunoblotted with KM1939 (lanes 1±5) or
control mouse IgG1 MoAb (lanes 6±10).
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results demonstrate that KM1939 is a highly speci®c MoAb reacting
with Fuc-TVII among closely related human a(1,3)-Fuc-T
families.
Immunohistochemical detection of Fuc-TVII by
MoAb Previous studies demonstrated that Fuc-TVII
mRNA was endogenously expressed at high levels in HL60
cells, but not in Namalwa and Jurkat cells (Sasaki et al, 1994;
Knibbs et al, 1996). We therefore investigated whether Fuc-
TVII protein expression in these cell lines could be
immunohistochemically detected by KM1939. Namalwa cells
before and after transfection with cDNA encoding Fuc-TVII
were included as negative and positive controls, respectively.
Moderate immunoreactivity to Fuc-TVII was readily detected in
the cytoplasm, but not the membrane, of HL60 cells (Fig 2A),
whereas no reactivity was noted in Namalwa (Fig 2E) and
Jurket cells (data not shown), in both of which corresponding
mRNA expression has not been demonstrated in the previous
studies. The staining was found in a supranuclear or perinuclear
location consistent with a Golgi staining pattern.
Nonpermeabilized HL60 cells showed no comparable staining
(data not shown), con®rming that this staining pattern was
intracellular. Transfection of Namalwa cells with Fuc-TVII
cDNA resulted in levels of Fuc-TVII protein expression greater
than those in HL60 cells (Fig 2C): in some of these cells, the
staining was more diffuse throughout the cytoplasm and
observed in the cell membrane. The speci®city of
immunohistochemical staining was con®rmed by replacing the
primary antibody with an irrelevant isotype-matched MoAb.
These results corroborated the accuracy of our staining
technique to speci®cally identify the Fuc-TVII protein in cell
lines.
We next investigated whether the expression of the CLA epitope
was selectively associated with the level of Fuc-TVII expression in
these cells lines. As shown in Fig 2(B), (D), and (F), a good
correlation was observed between the expression of CLA and the
enzyme expression level: transfection of Namalwa cells with Fuc-
TVII resulted in levels of CLA expression much greater than levels
endogenously expressed in HL60 cells, probably re¯ecting high
levels of Fuc-TVII activity. In addition to strong membrane
reactivity, slight Golgi staining for CLA was also noted in some
Namalwa/Fuc-TVII cells, but not HL60 cells.
Expression of Fuc-TVII in puri®ed CD4 and CD8 T
cells Previous ¯ow cytometric studies have shown that
although CLA+ cells can be detected in both CD4+ and CD8+ T
cell subsets from healthy volunteers, the CD4+ T cell subset
contains 2-fold more CLA+ cells than does the CD8+ subset
(Teraki et al, 2000). We therefore tested whether CD4+ and CD8+
T cells differed in the expression of the Fuc-TVII enzyme as well as
CLA expression. As shown in Fig 3 and Table I, there were
signi®cant numbers of CLA-expressing CD4+ T cells that did not
coexpress Fuc-TVII, and vice versa: 40% of CLA-expressing CD4+
T cells (4.2/10.4) coexpressed Fuc-TVII in a Golgi staining pattern.
A reaction product of KM1939 was seen intracellularly in a dot-like
or punctate pattern close to the cell surface. The intensity of
cytoplasmic Fuc-TVII staining, however, was not necessarily
proportional to that of CLA surface staining, unlike the cell lines.
Although cytoplasmic Fuc-TVII expression was also detectable in
puri®ed CD8+ T cell populations (data not shown), both the
percentage of Fuc-TVII expressing T cells and intensity of staining
were signi®cantly lower than those of CD4+ T cells, a ®nding
consistent with CLA expression: 30% of CLA+ CD8+ T cells (2.0/
6.6) coexpressed Fuc-TVII (Table I). Thus, according to the
expression pattern of CLA and Fuc-TVII, either the CD4+ or the
CD8+ T cell population can be further subdivided into three
populations: CLA+ Fuc-TVII+, CLA+ Fuc-TVII±, and CLA± Fuc-
TVII+. Regardless of whether CD4+ or CD8+ T cells were
analyzed, CLA+ Fuc-TVII± T cells were the most abundantly
identi®able phenotype. The percentages of Fuc-TVII-expressing
CD4+ and CD8+ T cells were roughly equivalent to those of CLA-
expressing CD4+ and CD8+ T cells, respectively, when stained
individually with either KM1939 or HECA-452 (Table I).
Altogether, these results indicate that CD4+ and CD8+ T cells
Figure 2. Immunohistochemical detection of
Fuc-TVII and CLA in HL-60 and Namalwa
cells. (A) Virtually all of the HL-60 cells show
immunoreactivity to Fuc-TVII in a supranuclear
location. (B) The majority of the HL-60 cells
express CLA in the cell membrane. (C) I ntense
reactivity to Fuc-TVII is seen in the Fuc-TVII-
transfected Namalwa cells. (D) Strong cell
membrane reactivity to CLA is noted in all of the
Fuc-TVII-transfected Namalwa cells. (E) No
reactivity to Fuc-TVII is noted in the Namalwa
cells. (F) No reactivity to CLA is found in the
Namalwa cells. Scale bar: 100 mm.
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differ in the frequency of Fuc-TVII expressing cells as demonstrated
previously in the frequency of CLA-expressing cells and that
expression of both proteins was not necessarily induced in a
synchronous fashion.
DISCUSSION
In this paper we report on a novel MoAb speci®c for the Fuc-TVII
enzyme. Thus far, methodologic approaches to determine the level
of Fuc-TVII expression in human cells have been performed only
with mRNA extracted from total cell populations; however, this
approach cannot easily address critical issues, such as the precise
expression of this enzyme in speci®c cell types during in¯ammation
and quantitative comparison of Fuc-TVII expression between
different cell populations and different tissue specimens. In this
regard, this MoAb KM1939 provides a means for the reliable
identi®cation of the enzyme in preparations of mixed cell
populations (this study) or in tissues (Mizukawa et al, 2001) by
immunohistochemistry. The obvious advantage of the immuno-
histochemical approach we employed here is that it allows the
evaluation of Fuc-TVII expression at the single cell level. This
method also has a number of advantages over the previously
employed RT-PCR technique, which relies on synthesis of
mRNA at the time of sample processing: the RT-PCR technique
fails to detect postranscriptioanl changes. Thus, our immunohisto-
chemical approach to detect the level of Fuc-TVII expression
promises to greatly simplify the cumbersome protocol of the RT-
PCR technique that is currently in use.
Nevertheless, it should be also pointed out that in PBMC, unlike
cell lines, the surface expression of the CLA epitope recognized by
HECA-452 was not always associated with the expression of Fuc-
TVII recognized by KM1939 in the cytoplasm: some T cells
expressed high levels of surface CLA but failed to express
cytoplasmic Fuc-TVII and vice versa. We cannot totally exclude
the possibility that some CLA- expressing peripheral blood T cells
would express Fuc-TVII at levels too low to identify accurately:
®xation and processing procedures we employed for ef®cient
staining may have reduced Fuc-TVII antigenicity. This possibility is
unlikely, however, because the frequencies of CD4+ T cells
expressing Fuc-TVII (10.1 6 1.0%) were very close to those
expressing CLA (11.8 6 1.8%) when stained individually. We
interpret these results as indicating that both CLA and Fuc-TVII
are expressed in the same T cell, but with different expression
kinetics. This is likely, because surface expression of CLA that is
subject to regulation by Fuc-TVII at the post-translational level
would be induced theoretically later than the induction of Fuc-
TVII. Indeed, our recent kinetic experiments using puri®ed CD4+
CLA± T cells show that cytoplasmic Fuc-TVII expression was
induced during the early stages of the immune response but was
sharply downregulated thereafter, whereas induction of CLA
expression occurred during the late stage, and that the CLA±
Fuc-TVII+ and CLA+ Fuc-TVII+ cells represented early activated
and late activated phenotypes, respectively (Takahashi et al, in
preparation). Our ®nding that this MoAb against Fuc-TVII can
mark a distinct subset of T cells (i.e., CLA± Fuc-TVII+) with skin
``homing'' properties that would be destined to become CLA
positive was important. Thus, our results indicate that skin
``homing'' T cells may be subdivided into three populations,
CLA+ Fuc-TVII+, CLA+ Fuc-TVII±, and CLA± Fuc-TVII+ cells.
The CLA epitope has been shown to be preferentially expressed
on type 1 cells during the differentiation process and in vitro
differentiated type 2 cells do not express CLA (Akdis et al, 2000).
Apparently inconsistent with this ®nding, however, is the high
frequency of CLA+ type 2 cells in the lesional skin and circulation
of patients with atopic dermatitis (Akdis et al, 1999). In this regard,
Akdis et al attempted to reconcile these contradictory results (Akdis
et al, 2000): they demonstrated that CLA expression was induced
even on primed type 2 cells upon stimulation with IL-12 and/or
superantigens, and suggested that Langerhans cells and macrophages
in the skin could provide IL-12 required for the induction of the
CLA expression on type 2 cells. It is of interest therefore to
investigate the cytokine pro®le of Fuc-TVII+ T cells demonstrated
here. Because simultaneous immunohistochemical identi®cation of
Fuc-TVII and cytokines in the cytoplasm of the individual T cell
was technically not possible at this time, we are now conducting
experiments to determine whether Fuc-TVII is preferentially
expressed either in in vitro differentiated type 1 or in type 2 cells
from healthy controls and atopic patients, and which cytokines
could induce Fuc-TVII expression on these T cells.
In conclusion, our study provides convincing evidence that Fuc-
TVII expression, in combination with CLA expression, is a useful
phenotypic marker for identifying skin ``homing'' T cells.
Table I. Expression of Fuc-TVII and CLA in CD4+ and CD8+ T cells puri®ed from PBMC of ®ve healthy controlsa
T cells
Double stainingb Single stainingc
CLA+ Fuc-TVII+ CLA+ Fuc-TVII- CLA- Fuc-TVII+ total CLA+ d total Fuc-TVII+ e CLA+ Fuc-TVII+
CD4 4.260.7 6.260.7 3.260.6 10.460.7 7.361.0 11.861.8f 10.161.0g
CD8 2.060.2 4.660.9 2.160.4 6.660.9 4.260.5 8.462.4f 5.761.3g
aPercentages of CD4+ or CD8+ T cells expressing each Ag. Data are expressed as mean 6 SEM.
bThese T cells were stained double with both anti-Fuc-TVII and anti-CLA mAb.
cThese T cells were stained singly with either anti-Fuc-TVII or anti-CLA.
dThe combined percentages of CLA+ Fuc-TVII+ cells and CLA+ Fuc-TVII± cells.
eThe combined percentages of CLA+ Fuc-TVII+ cells and CLA± Fuc-TVII+ cells.
fThe Student's t test was used to determine the signi®cance of differences in samples. No signi®cant differences were noted between CD4+ and CD8+ T cells in CLA
expression.
gDifference between CD4+ and CD8+ T cells in Fuc-TVII expression was statistically signi®cant (p < 0.05). No signi®cant differences were noted between CLA+ and
Fuc-TVII+ cells in either CD4+ or CD8+ T cells.
Figure 3. Double immunohistochemical detection of Fuc-TVII
and CLA in puri®ed CD4+ T cells. Dot-like expression of Fuc-TVII
(red) is detected in the cytoplasm of some CD4+ T cells showing the
intense membrane CLA staining (blue). Scale bar: 10 mm.
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